Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Certain drugs that block specific enzymes can help treat prostate diseases.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Testosterone may influence COVID-19 severity and outcomes.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Feeling younger can improve health and extend life.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Computational methods help design drugs targeting prostate cancer proteins.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.